Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002858893 | SCV003618673 | uncertain significance | Inborn genetic diseases | 2022-04-25 | criteria provided, single submitter | clinical testing | The c.1343T>A (p.M448K) alteration is located in exon 5 (coding exon 5) of the GCM2 gene. This alteration results from a T to A substitution at nucleotide position 1343, causing the methionine (M) at amino acid position 448 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005036565 | SCV005665913 | uncertain significance | Hyperparathyroidism 4; Hypoparathyroidism, familial isolated, 2 | 2024-02-03 | criteria provided, single submitter | clinical testing |